EGFR and breast carcinoma: Human epidermal growth factor receptor 2 (HER-2) is a member of epidermal growth factor receptor (EGFR) family, which is overexpressed in breast cancer, ovary cancer, uterine endometrioid carcinoma, gastric carcinomas, glioblastomas, etc (Jackson et al., 2013).